Viewing Study NCT00031733

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-03-06 @ 12:34 AM
Study NCT ID: NCT00031733
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2002-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Sponsor: University of Southern California
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intraocular Melanoma View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None iris melanoma View
None ciliary body and choroid melanoma, small size View
None ciliary body and choroid melanoma, medium/large size View
None extraocular extension melanoma View
None recurrent intraocular melanoma View
None stage II melanoma View
None stage III melanoma View
None stage IV melanoma View
None recurrent melanoma View